Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q4 2016 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$65.86K$65.86Kderivedno prior Q4 2015 on file Net Income-$2.28M-$2.28MderivedN/M vs Q4 2015 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$28,930— Operating Incomederived-$1,199,249— Operating Cash Flowderived-$921,816N/M Margins · derivedGross margin43.9%
Operating margin-1821.0%
Net margin-3458.3%
ended Dec 31, 2016 · filed Mar 30, 2017 · 89 d after period end